Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Thyrocare Technologies Ltd ( (IN:THYROCARE) ) has shared an announcement.
Thyrocare Technologies Ltd has published its audited financial results for the quarter and full year ended March 31, 2026 in leading Marathi and English newspapers, in line with SEBI’s Listing Regulations. The company has also provided a QR code for investors to access the complete results and made the advertisement and detailed financial statements available on its investor relations website, reinforcing transparency and regulatory compliance.
The disclosure ensures shareholders and market participants can review Thyrocare’s latest audited performance, which is expected to inform investment decisions and support orderly trading in its shares. By disseminating the results simultaneously through stock exchanges and multiple media channels, Thyrocare underscores its commitment to timely public communication and strengthens its standing within India’s regulated capital markets framework.
More about Thyrocare Technologies Ltd
Thyrocare Technologies Ltd is an Indian diagnostics company focused on preventive healthcare and pathology testing, with a strong presence in specialised diagnostic services. It operates through a network of laboratories and collection centres, catering to retail patients, hospitals and corporates, and is listed on both the National Stock Exchange of India and BSE.
Average Trading Volume: 24,092
Technical Sentiment Signal: Buy
Current Market Cap: 77.27B INR
For an in-depth examination of THYROCARE stock, go to TipRanks’ Overview page.